Effect of Dentin Conditioning with Intracanal Medicaments on Survival of Stem Cells of Apical Papilla
Overview
Affiliations
Introduction: Regenerative endodontics is a valuable treatment modality for immature teeth with pulpal necrosis. A common feature in regenerative cases is the use of intracanal medicaments. Although these medicaments are chosen because of their antibacterial properties, their enduring effect on dentin (conditioning) and the subsequent impact on stem cell survival has never been evaluated. In this study, we hypothesized that triple antibiotic paste (TAP), double antibiotic paste (DAP), or Ca(OH)2 has an indirect adverse effect on the survival of stem cells of apical papilla (SCAP) by dentin conditioning.
Methods: Human dentin disks were created with a standardized root canal diameter of 3.2 mm. The disks were then exposed to either TAP or DAP (at concentrations of 1 mg/mL or 1000 mg/mL), Ca(OH)2 (Ultracal), or Hank's balanced salt solution for 7 or 28 days. Next, the medicaments were removed with copious irrigation, followed by placement of SCAP in a Matrigel scaffold in the lumen of the disks. The bioengineered constructs were cultured for 7 days, followed by determination of cellular viability by using the CellTiter-Glo luminescence assay. Data were analyzed using 1-way analysis of variance with Bonferroni post hoc test.
Results: Exposure of dentin to TAP or DAP at 1000 mg/mL resulted in no viable SCAP, whereas the use of these medicaments at 1 mg/mL had no adverse effect on cell viability. In contrast, Ca(OH)2 treatment significantly increased SCAP survival and proliferation when compared with the control group.
Conclusions: Dentin conditioning with TAP and DAP at commonly used clinical concentration (approximately 1000 mg/mL) alters dentin in such a way as to prevent SCAP survival. This lethal indirect effect of both TAP and DAP can be largely avoided if these medicaments are used at the 1 mg/mL concentration. Conversely, dentin conditioning with Ca(OH)2 promotes SCAP survival and proliferation.
Afhkami F, Ahmadi P, Rostami G Clin Exp Dent Res. 2025; 11(1):e70075.
PMID: 39967043 PMC: 11835769. DOI: 10.1002/cre2.70075.
Sellami R, Van Holm W, Meschi N, Van Den Heuvel S, Pauwels M, Verspecht T Front Dent Med. 2025; 4:1281337.
PMID: 39916917 PMC: 11797765. DOI: 10.3389/fdmed.2023.1281337.
Injectable thermosensitive antibiotic-laden chitosan hydrogel for regenerative endodontics.
Reis-Prado A, Rahimnejad M, Dal-Fabbro R, de Toledo P, Anselmi C, de Oliveira P Bioact Mater. 2025; 46:406-422.
PMID: 39850022 PMC: 11754974. DOI: 10.1016/j.bioactmat.2024.12.026.
Koyuncuoglu G, Aren G Ulus Travma Acil Cerrahi Derg. 2025; 31(1):23-31.
PMID: 39775507 PMC: 11843395. DOI: 10.14744/tjtes.2024.31532.
Fouad E, Fawzy M, Saafan A, Elhousiny M BMC Oral Health. 2024; 24(1):1430.
PMID: 39580417 PMC: 11585143. DOI: 10.1186/s12903-024-05189-3.